График акции American Oncology Network, Inc.
Расширенный график
Простой график
О компании
American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida.
| Цена ао |
5.97 |
| Выручка |
0.7247 |
| ISIN |
US0287191029 |
| Сайт |
https://www.aoncology.com
|
| EBITDA |
0.0259 |
| EV/EBITDA |
4.63 |
| Число акций ао |
0.00952 млрд |
| P/S |
0.0439 |
| P/BV |
9.81 |
| P/E |
36.98 |
| Валюта |
usd |
| IPO date |
2021-05-05 |
| Sector |
Health Care |
| Industry |
Health Care Providers & Services |
| Валюта отчета |
usd |
| Изменение цены за день: |
0% (3.65) |
| Изменение цены за неделю: |
+10.61% (3.3) |
| Изменение цены за месяц: |
+7.67% (3.39) |
| Изменение цены за 3 месяца: |
+196.75% (1.23) |
| Изменение цены за полгода: |
-33.76% (5.51) |
| Изменение цены за год: |
-64.93% (10.408) |
| Изменение цены за 3 года: |
-62.37% (9.7) |
| Изменение цены с начала года: |
-39.17% (6) |
|
|
Недооценка
| Название |
Значение |
Оценка |
| P/S |
0.0304 |
10 |
| P/BV |
6.78 |
1 |
| P/E |
0 |
0 |
| EV/EBITDA |
531.14 |
1 |
| Итого: |
|
5.25 |
|
Эффективность
| Название |
Значение |
Оценка |
| ROA, % |
-1.5819 |
0 |
| ROE, % |
6.3 |
2 |
| Итого: |
|
0.5 |
|
|
|
Дивиденды
| Название |
Значение |
Оценка |
| Div yield, % |
0 |
0 |
| DSI |
0 |
0 |
| Итого: |
|
0 |
|
Долг
| Название |
Значение |
Оценка |
| Debt/EBITDA |
491.57 |
0 |
| Итого: |
|
6 |
|
Импульс роста
| Название |
Значение |
Оценка |
| Доходность Revenue, % |
76.51 |
8 |
| Доходность Ebitda, % |
-98.99 |
0 |
| Доходность EPS, % |
-136.04 |
0 |
| Итого: |
|
1.6 |
|
| Руководитель |
Должность |
Оплата |
Год рождения |
| Mr. Todd Schonherz |
CEO & Director |
2.25M |
1970 (54 года) |
| Dr. Stephen Divers M.D. |
Chief Medical Officer, VC of Board of Managers & Chairman of Advisory Board Executive Committee |
1.7M |
1974 (50 лет) |
| Mr. Mark Moch |
Chief Information Officer |
N/A |
|
| Ms. Kristin Matisziw |
Chief Compliance & Risk Officer |
N/A |
|
| Ms. Erica Mallon |
General Counsel |
N/A |
1988 (36 лет) |
| Ms. Caroline Hewitt |
Vice President of Marketing |
N/A |
|
| Mr. James Gilmore Pharm.D. |
Chief Pharmacy & Clinical Services Officer |
N/A |
|
| Ms. Karen Pilley |
Chief Revenue Cycle Officer |
N/A |
|
| Mr. Anthony V. Belott |
Chief Development Officer |
N/A |
|
| Mr. David Afshar CPA |
Principal Accounting Officer, CFO & COO |
|
1972 (52 года) |
